Florida is emerging as a global leader in cancer innovation—where technology, research, and compassion converge to transform how humanity confronts one of its greatest medical challenges. At the forefront of this movement, The Florida High Tech Corridor is accelerating collaboration among universities, startups, and industry partners to strengthen the state’s rapidly growing life sciences ecosystem. Through targeted grants, talent development initiatives, and strategic connections, the Corridor helps turn groundbreaking research into real-world medical solutions that are reshaping the future of cancer care.

One shining example of this innovation is found in Sanford, just 30 minutes from Orlando, where Dot Decimal—a trusted medical device manufacturer since 1986—has long specialized in designing custom radiation treatment fields with unmatched precision. Today, the company is pioneering Flash Therapy, a breakthrough technology that delivers ultra-targeted radiation doses in a fraction of a second. This approach not only reduces side effects but also dramatically shortens treatment times, setting a new global standard for patient-centered cancer care.

Equally transformative, Protean BioDiagnostics has developed an advanced genomic risk assessment test that vastly expands cancer screening capabilities. With unprecedented coverage of the human genome, Protean’s technology allows clinicians to detect risks earlier and more frequently, empowering prevention and early intervention on a scale the world has never seen.

Orlando Health’s Cancer Institute is redefining oncology in Florida through precision medicine, advanced genomics, and AI-driven research—integrating clinical excellence with groundbreaking innovation to deliver highly personalized cancer care and accelerate the discovery of next-generation therapies. At the forefront of this effort, the Orlando Health Digestive Health Institute is pioneering the use of artificial intelligence for the early diagnosis of pancreatic cancer, advancing the fight against one of the most challenging and deadly diseases.

Moffitt Cancer Center in Tampa is the state’s only National Cancer Institute-designated Comprehensive Cancer Center and Florida’s #1 cancer hospital for 2025, is leading the fight against cancer through groundbreaking research, advanced clinical trials, and personalized therapies. Its newest initiative, AccelerOnco Studio, is the nation’s first venture studio devoted exclusively to oncology innovation, transforming cutting-edge ideas into lifesaving breakthroughs and reinforcing Moffitt’s role as a national leader in cancer care.

And in Jacksonville, the Mayo Clinic is preparing to open the Western Hemisphere’s first Carbon Ion Therapy Program by 2028. This extraordinary technology uses charged carbon ions to obliterate even the most aggressive or radiation-resistant tumors with surgical precision while preserving surrounding tissue. Expected to attract patients from around the world, Mayo’s program will place Florida at the epicenter of next-generation cancer treatment.

Together, these pioneering efforts are not just changing cancer care in Florida, they are reshaping it for the entire world. From early detection to advanced therapy, Florida’s innovation is lighting the path toward a future where cancer is no longer a death sentence, but a disease that can be defeated.